Sialyl cholesterol enhances the development of grafted neurons and motor recovery.
Trophic actions of alpha-sialyl cholesterol (SC) and its sialidase-tolerant derivative, alpha-(3 beta-hydroxysialyl) cholesterol (SCt), were carried out on the development of midbrain neurons both in vitro and in vivo transplantation studies. Low to moderate concentrations of SC (0.01 to 0.05 micrograms/ml) facilitated neurite extension but had no effects on cell survival of primary cultured midbrain neurons. However, high concentration of SC (0.1 micrograms/ml) disturbed both neurite genesis and cell survival. SCt had a similar effect on midbrain neurons. At higher concentrations, SC and SCt induced concentration-dependent morphological changes in astrocytes from flat to fibrous. The effect on astrocytes was stronger in SCt than SC. At highest concentration tested (20 micrograms/ml), the proliferation of astrocytes was completely blocked, cells became detached and finally died. This effect of SC and SCt was partially blocked by simultaneous application of aFGF. Following dopaminergic cell grafting in vivo, SC and SCt had biphasic effects: a low dose (0.2 mg/kg, SC) enhanced motor recovery at 4 and 6 weeks after transplantation, while the highest dose (20 mg/kg, SC) disturbed motor recovery at all periods tested. These effects on motor recovery were paralleled by an effect on neurite genesis as studied by tyrosine hydroxylase immunostaining. Thus, at low concentrations, SC and SCt are neurotrophic agents that stimulate the development and differentiation of dopaminergic neurons.
Hashitani
T
T
Department of Physiology, Nagoya City University Medical School, Japan.
Furuyama
F
F
Kumazaki
M
M
Zhou
X R
XR
Geller
H M
HM
Toyomaki
Y
Y
Okamoto
K
K
Oomura
Y
Y
Nishino
H
H
D000818:Animals; D000831:Animals, Newborn; D001253:Astrocytes / Q000166:cytology* / Q000187:drug effects; D016380:Brain Tissue Transplantation / Q000502:physiology*; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000166:cytology; D002788:Cholesterol Esters / Q000494:pharmacology*; D016332:Fetal Tissue Transplantation / Q000502:physiology; D005904:Glial Fibrillary Acidic Protein / Q000032:analysis; D008636:Mesencephalon / Q000166:cytology / Q000187:drug effects / Q000637:transplantation*; D009043:Motor Activity / Q000187:drug effects*; D016900:Neurofilament Proteins / Q000032:analysis; D009474:Neurons / Q000187:drug effects / Q000502:physiology* / Q000637:transplantation*; D016627:Oxidopamine; D051381:Rats; D017208:Rats, Wistar; D012399:Rotation; D012794:Sialic Acids / Q000494:pharmacology*; D013378:Substantia Nigra / Q000187:drug effects / Q000473:pathology / Q000502:physiology; D013997:Time Factors
D002788:Cholesterol Esters; D005904:Glial Fibrillary Acidic Protein; D016900:Neurofilament Proteins; D012794:Sialic Acids; C055195:N-acetylneuraminyl cholesterol; C078958:alpha-(3-hydroxysialyl)cholesterol; D016627:Oxidopamine